Cellular mechanisms of risk and transformation

Annals of the New York Academy of Sciences

Volumn 889, Issue , 1999, Pages 20-31

  Augenlicht, Leonard H ^a   Bordonaro, Michael ^a,b   Heerdt, Barbara G ^a   Mariadason, John ^a   Velcich, Anna ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA;

APOPTOSIS; CANCER RISK; CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL TRANSFORMATION; COLON MUCOSA; CONFERENCE PAPER; DNA SEQUENCE; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; IMAGING; MITOCHONDRION; NONHUMAN; PROBABILITY; SIGNAL TRANSDUCTION;

EID: 0033428147     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08720.x     Document Type: Conference Paper

References (59)

1. 1. Augeron, C. & C.L. Laboisse. 1984. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res. 44: 3961-3969.
2. 2. Augenlicht, L.H., G.M. Anthony, T.L. Chruch, W. Edelmann, R. Kucherlapati, K.Y. Yang, M. Lipkin & B.G. Heerdt. Short chain fatty acid metabolism, apoptosis and Apc initiated tumorigenesis in the mouse gastrointestinal mucosa. Submitted.
3. 3. Smith, K.J., K.A. Johnson, T.M. Bryan, D.E. Hill, S. Markowitz, J.K.V. Willson, C. Paraskeva, G.M. Petersen, S.R. Hamilton, B. Vogelstein & K.W. Kinzler. 1993. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA 90:2846-2850.
4. 4. El-Deiry, W.S., T. Tokino, T. Waldman, J.D. Oliner, V.E. Velculescu, M. Burrell, D.E. Hill, E. Healy, J.L. Rees, S. R. Hamilton, K.W. Kinzler & B. Vogelstein. 1995. Topological control of p21 waf1/cip1 expression in normal and neoplastic tissues. Cancer Res. 55: 2910-2919.
5. 5. Melhem, M.F., A.I. Meisler, G.G. Finley, W.H. Bryce, M.O. Jones, I.I. Tribby, J.M. Pipas & R.A. Koski. 1992. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors. Cancer Res. 52: 5853-5864.
6. 6. Chin, L., N. Schreiber-Agus, I. Pellicer, K. Chen, H.-W. Lee, M. Dudast, C. Cordon-Cardo & R.A. DePinho. 1995. Contrasting roles for myc and mad proteins in cellular growth and differentiation. Proc. Natl. Acad. Sci. USA 92: 8488-8492.
7. 7. Augenlicht, L.H., M.Z. Wahrman, H. Halsey, L. Anderson, J. Taylor & M. Lipkin. 1987. Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro. Cancer Res. 47: 6017-6021.
8. 8. Augenlicht, L.H., J. Taylor, L. Anderson & M. Lipkin. 1991. Patterns of gene expression that characterize the colonic mucosa in patients at genetic risk for colonic cancer. Proc. Natl. Acad. Sci. USA 88: 3286-3289.
9. 9. Heerdt, B.G., H.K. Halsey, M. Lipkin & L.H. Augenlicht. 1990. Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer. Cancer Res. 50: 1596-1600.
10. 10. Kim, Y.S., D. Tsao, B. Siddiqui, J.S. Whitehead, P. Arnstein, J. Bennett & J. Hicks. 1980. Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer 45:1185-1192.
11. 11. Morita, A., D. Tsao & Y.S. Kim. 1982. Effect of sodium butyrate on alkaline phosphatase in HRT-18, a human rectal cancer cell line. Cancer Res. 42: 4540-4545.
12. 12. Tsao, D., Z.-R. Shi, A. Wong & Y.S. Kim. 1983. Effect of sodium butyrate on carcinoembryonic antigen production by human colonic adenocarcinoma cells in culture. Cancer Res. 43: 1217-1222.
13. 13. Cummings, J.H., E.W. Pomare, W.J. Branch, C.P.E. Naylor & G.T. Macfarlane. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221-1227.
14. 14. Harig, J.M., K.H. Soergel, R.A. Komorowski & C.M. Wood. 1989. Treatment of diversion colitis with short-chain-fatty acid irrigation. N. Engl. J. Med. 320: 23-28.
15. 15. Roediger, W.E. 1980. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21: 793-798.
16. 16. Heerdt, B.G. & L.H. Augenlicht. 1991. Effects of fatty acids on expression of genes encoding subunits of cytochrome c oxidase and cytochrome c oxidase activity in HT29 human colonic adenocarcinoma cells. J. Biol. Chem. 266: 19120-19126.
17. 17. Heerdt, B.G., M.A. Houston & L.H. Augenlicht. 1994. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. 54: 3288-3294.
18. 18. Hague, A., A.M. Manning, K.A. Hanlon, L.I. Huschtscha, D. Hart & C. Paraskeva. 1993. Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer 55: 498-505.
19. 19. Heerdt, B.G., M.A. Houston, J.J. Rediske & L.H. Augenlicht. 1996. Steady-state levels of mitochondrial messenger RNA species characterize a predominant pathway culminating in apoptosis and shedding of HT29 human colonic carcinoma cells. Cell Growth & Differen. 7: 101-106.
20. 20. Heerdt, B. G., M.A. Houston & L.H. Augenlicht. 1997. Short chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth & Differen. 8: 523-532.
21. 21. Heerdt, B.G., M.A. Houston, G.M. Anthony & L.H. Augenlicht. 1998. Mitochondrial membrane potential in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Res. 58: 2869-2875.
22. 22. Reed, J. C. 1997. Cytochrome c: Can't live with it - Can't live without it. Cell 91: 559-562.
23. 23. Marchetti, P., S.A. Susin, D. Decaudin, S. Gamen, M. Castedo, T. Hirsch, N. Zamzami, J. Naval, A. Senik & G. Kroemer. 1996. Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res. 56: 2033-2038.
24. 24. Zamzami, N., S.A. Susin, P. Marchetti, T. Hirsch, I. Gomez-Monterrey, M. Castedo, & G. Kroemer. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183: 1533-1544.
25. 25. Rubinfeld, B., B. Souza, I. Albert, O. Muller, S.H. Chamberlain, F.R. Masiarz, S. Munemitsu, P. Polakis. 1993. Association of the APC gene product with β-catenin. Science 262: 1731-1734.
26. 26. Su, L.-K., B. Vogelstein & K. Kinzler. 1993. Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737.
27. 27. Munemitsu, S., I. Albert, B. Souza, B. Rubinfeld & P. Polakis. 1995. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Nalt. Acad. Sci. USA 92: 3046-3050.
28. 28. Molenaar, M., M. van de Wetering, M. Osterwegel, J. Peterson-Maduro, S. Godsave, V. Korinek, J. Roose, O. Destree & H. Clevers. 1996. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86: 391-399.
29. 29. Behrens, J., J.P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl & W. Birchmeier. 1996. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638-642.
30. 30. Korinek, V., N. Barker, P.J. Morin, D. van Wichen, R. de Weger, K.W. Kinzler, B. Vogelstein & H. Clevers. 1997. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science 275: 1784-1787.
31. 31. Morin, P.J., A.B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein & K.W. Kinzler. 1997. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 787-1790.
32. 32. Bordonaro, M., J.M. Mariadason, B.G. Heerdt & L.H. Augenlicht. 1999. Butyrate induced cell cycle arrest and apoptotic cascade in colonic carcinoma cells: Modulation of the β-catenin-Tcf pathway, and concordance with effects of Sulindac and trichostatin, but not curcumin. Cell Growth & Differen. In press.
33. 33. Ahmed, Y., S. Hayashi, A. Levine & E. Wieschaus. 1998. Regulation of Armadillo by a Drosophila APC inhibits neuronal apoptosis during retinal development. Cell 93: 1171-1182.
34. 34. Morin, P.J., B. Vogelstein & K.W. Kinzler. 1996. Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA 93: 7950-7954.
35. 35. He, T.-C., A.B. Sparks, C. Rago, H. Hermeking, L. Zawel, L.T. da Costa, P.J. Morin, B. Vogelstein & K.W. Kinzler. 1998. Identification of c-myc as a target of the APC pathway. Science 281: 1509-1512.
36. 36. Yander, G., H. Halsey, M. Kenna & L.H. Augenlicht. 1985. Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor. Cancer Res. 45: 4433-4438.
37. 37. Heerdt, B.G., S. Molinas, D. Deitch & L.H. Augenlicht. 1991. Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-myc gene. Oncogene 6: 125-129.
38. 38. Augenlicht, L.H., S. Wadler, G. Corner, C. Richards, L. Ryan, A.S. Multani, S. Pathak, A. Benson, D. Haller & B.G. Heerdt. 1997. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: A frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res. 57: 1769-1775.
39. 39. Erisman, M.D., J.K. Scott, R.A. Watt & S.M. Astrin. 1988. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. Oncogene 2: 367-378.
40. 40. Erisman, M.D., P.G. Rothberg, R.E. Diehl, C.C. Morse, J.M. Spandorfer & S.M. Astrin. 1985. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol. Cell. Biol. 5: 1969-1976.
41. 41. Herold, K.M. & P.G. Rothberg. 1988. Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. Oncogene 3: 423-428.
42. 42. Taylor, C.W., Y.S. Kim, K.E. Childress-Fields & L.C. Yeoman. 1992. Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines. Cancer Lett. 62: 95-105.
43. 43. Collins, J.F., P. Herman, C. Schuch & G.C. Bagby. 1992. c-myc antisense oligo-nucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells. J. Clin. Invest. 89:1523-1527.
44. 44. Heruth, D.P., G.W. Zirnstein, J.F. Bradley & P.G. Rothberg. 1993. Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J. Biol. Chem. 268: 20466-20472.
45. 45. Barnard, J.A. & G. Warwick. 1993. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth & Differen. 4: 495-501.
46. 46. Groden, J., G. Joslyn, W. Samowitz, D. Jones, N. Bhattacharyya, L. Spirio, A. Thliveris, M. Robertson, S. Egan, M. Meuth & R. White. 1995. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res. 55: 1531-1539.
47. 47. Bedi, A., P.J. Pasricha, A.J. Akhtar, J.P. Barber, G.C. Bedi, F.M. Giardiello, B.A. Zehnbauer, S.R. Hamilton & R.J. Jones. 1995. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55: 1811-1816.
48. 48. Boolbol, S.K., A.J. Dannenberg, A. Chadburn, C. Martucci, X.J. Guo, J.T. Ramonetti, M. Abreu-Goris, H.L. Newmark, M. Lipkin, J.J. DeCosse & M.M. Bertagnolli. 1996. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56: 2556-2560.
49. 49. Pretlow, T.P., B. Siddiki, L.H. Augenlicht, T.G. Pretlow & Y.S. Kim. 1999. Aberrant crypt foci (ACF) - earliest recognized players or innocent bystanders in colon carcinogenesis. In Colorectal Cancer: Molecular Mechanisms, Premalignant State, and its Prevention. W. Schmiegel, Ed.: Kluwer Academic Publishers. Lancaster, England.
50. 50. Velcich, A. & L.H. Augenlicht. 1993. Regulated expression of an intestinal mucin gene in HT29 colonic carcinoma cells. J. Biol. Chem. 268: 13956-13961.
51. 51. Velcich, A., L. Palumbo, A. Jarry, C. Laboisse, J. Racevskis & L. Augenlicht. 1995. Patterns of expression of lineage specific markers during the in vitro differentiation of HT29 colon carcinoma cells. Cell Growth & Differen. 6: 749-757.
52. 52. Velcich, A., L. Palumbo, L. Selleri, G. Evans & L. Augenlicht. 1997. Organization and regulatory aspects of the human intestinal mucin gene (MUC2) locus. J. Biol. Chem. 272: 7968-7976.
53. 53. Warthin, A.S. 1913. Heredity with reference to carcinoma. Arch. Intern. Med. 12: 546-555.
54. 54. Lynch, H.T. & A.J. Krush. 1971. Cancer family G revisited: 1895-1970. Cancer 27: 1505-1511.
55. 55. Marra, G. & C.R. Boland. 1995. Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst. 87: 1114-1125.
56. 56. Fodde, R., W. Edelmann, K. Yang, C. Van Leeuwen, C. Carlson, B. Renault, C. Breukel, E. Alt, M. Lipkin, P.M. Khan & R. Kucherlapati. 1994. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA 91: 8969-8973.
57. 57. Yang, K., W. Edelmann, K. Fan, K. Lau, V.R. Kolli, R. Fodde, P.M. Khan, R. Kucherlapati & M. Lipkin. 1997. A mouse model of human familial adenomatous polyposis. J. Exp. Zool. 277: 245-254.
58. 58. Su, L.-K., K.W. Kinzler, B. Vogelstein, A.C. Preisinger, A.R. Moser, C. Luongo, K.A. Gould & W.F. Dove. 1992. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670.
59. 59. Oshima, M., H. Oshima, K. Kitagawa, M. Kobayashi, C. Itakura & M. Taketo. 1995. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA 92: 4482-4486.